LIFD
Price
$0.28
Change
+$0.02 (+7.69%)
Updated
Dec 10 closing price
Capitalization
4.15M
Intraday BUY SELL Signals
Interact to see
Advertisement

LIFD

Header iconLIFD Comparison
Open Charts LIFDBanner chart's image
LFTD Partners
Price$0.28
Change+$0.02 (+7.69%)
Volume$1.3K
Capitalization4.15M
LIFD Comparison Chart in %
LIFD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.29B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 1%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 19%. TEVJF experienced the highest price growth at 55%, while RGTLF experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -18% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 62
Price Growth Rating: 58
SMR Rating: 80
Profit Risk Rating: 89
Seasonality Score: 23 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (LIFD: $0.28)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIFD’s FA Score shows that 1 FA rating(s) are green while.

  • LIFD’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIFD’s TA Score shows that 5 TA indicator(s) are bullish.

  • LIFD’s TA Score: 5 bullish, 4 bearish.

Price Growth

LIFD (@Pharmaceuticals: Generic) experienced а +7.58% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.50%. For the same industry, the average monthly price growth was -1.01%, and the average quarterly price growth was +19.25%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.50% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIFD
Capitalization4.15M
EBITDA-11.91K
Gain YTD-42.918
P/E Ratio13.93
Revenue36.6M
Total Cash2.12M
Total Debt4.38M
FUNDAMENTALS RATINGS
LIFD: Fundamental Ratings
LIFD
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
29
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LIFD
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LIFD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI7.000.52
+8.02%
Karyopharm Therapeutics Inc.
SMBK39.751.15
+2.98%
SmartFinancial
WU9.610.15
+1.59%
Western Union Company (The)
FAMI1.500.02
+1.02%
Farmmi Inc
IP39.05-0.07
-0.18%
International Paper Co

LIFD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LIFD has been loosely correlated with LVZPF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIFD jumps, then LVZPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIFD
1D Price
Change %
LIFD100%
N/A
LVZPF - LIFD
34%
Loosely correlated
N/A
CRRTF - LIFD
29%
Poorly correlated
N/A
BFRI - LIFD
6%
Poorly correlated
+0.02%
HLN - LIFD
5%
Poorly correlated
+1.37%
SHPH - LIFD
3%
Poorly correlated
-3.24%
More